Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Recap: Cellectar Biosciences Q1 Earnings

Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences reported in-line EPS of $-0.1 versus an estimate of $-0.1.

Benzinga

Check Out What Whales Are Doing With GOOGL

Someone with a lot of money to spend has taken a bearish stance on Alphabet (NASDAQ:GOOGL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Telos Registers 10% Revenue Decline In Q1; Reaffirms FY22 Guidance

Telos Corp (NASDAQ:TLS) reported a first-quarter FY22 revenue decline of 10% year-on-year to $50.2 million. Services revenue declined 7.6% Y/Y to $48.1 million. The gross margin expanded by 1,160 bps to 37.6%. Adjusted EPS loss was $(0.01). Telos generated $0.25 million in operating cash flow in the quarter and held $120.2 million in…

Benzinga

So What's Going On With SoFi Technologies Shares Today?

SoFi Technologies Inc (NASDAQ: SOFI) shares are trading lower by 10.05% at $5.37.

Benzinga

Pieris Pharmaceuticals's Earnings Outlook

Pieris Pharmaceuticals (NASDAQ:PIRS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Pieris Pharmaceuticals will report an earnings per share (EPS) of $-0.11.

Benzinga

Expert Ratings for EverCommerce

EverCommerce (NASDAQ:EVCM) has observed the following analyst ratings within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Outlook For Ontrak

Ontrak (NASDAQ:OTRK) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Ontrak will report an earnings per share (EPS) of $-0.72.

Benzinga

What Are Whales Doing With Apple

Someone with a lot of money to spend has taken a bearish stance on Apple (NASDAQ:AAPL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

A Preview Of SunOpta's Earnings

SunOpta (NASDAQ:STKL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that SunOpta will report an earnings per share (EPS) of $-0.02.

Benzinga

This Is What Whales Are Betting On Airbnb

Someone with a lot of money to spend has taken a bearish stance on Airbnb (NASDAQ:ABNB). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Corbus Pharmaceuticals: Q1 Earnings Insights

Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Delcath Systems Q1 Earnings

Delcath Systems (NASDAQ:DCTH) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Avrobio: Q1 Earnings Insights

Avrobio (NASDAQ:AVRO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: Stoke Therapeutics Q1 Earnings

Stoke Therapeutics (NASDAQ:STOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Stoke Therapeutics reported an EPS of $-0.66.

Benzinga

5 Analysts Have This to Say About Global E Online

Global E Online (NASDAQ:GLBE) has observed the following analyst ratings within the last quarter:

Benzinga

Looking At NVIDIA's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on NVIDIA. Looking at options history for NVIDIA (NASDAQ:NVDA) we detected 14 strange trades.

Benzinga

Expert Ratings for PayPal Holdings

PayPal Holdings (NASDAQ:PYPL) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga

Analyzing Google's Short Interest

Alphabet's (NASDAQ:GOOGL) short percent of float has fallen 11.94% since its last report. The company recently reported that it has 1.78 million shares sold short, which is 0.59% of all regular shares that are available for trading.

Benzinga

Preview: Hanover Bancorp, Inc. Set To IPO Tomorrow

Hanover Bancorp, Inc. (NASDAQ:HNVR) IPO will take place May, 11 on the NASDAQ exchange under the ticker HNVR. The company is offering shares at an expected price between $21.00 and $23.00 per share with an insider lock-up period of 180 days ending on November 07, 2022.

Benzinga

Wytec International, Inc To Start Trading Tomorrow

Wytec International, Inc (NASDAQ:WYTC) IPO will take place May, 11 on the NASDAQ exchange under the ticker WYTC. The company is offering shares at an expected price of $4.25 per share with an insider lock-up period of 180 days ending on November 07, 2022.

Benzinga

Henry Schein's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Henry Schein (NASDAQ:HSIC) posted Q1 earnings of $186.00 million, an increase from Q4 of 22.25%. Sales dropped to $3.18 billion, a 4.56% decrease between quarters.

Benzinga

Zealand Pharma Amends Financing Agreement With Oberland Capital

Zealand Pharma A/S (NASDAQ:ZEAL) has amended its existing financing agreement with Oberland Capital Management LLC, under which Zealand will repurchase $50 million of note principal with a 1.2x prepayment premium. Oberland Capital will provide Zealand with up to $75.0 million in incremental capital, of which $50.0 million is to be reserved for M&A…

Benzinga

Itron's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Itron (NASDAQ:ITRI) posted Q1 earnings of $896.00 thousand, an increase from Q4 of 101.53%. Sales dropped to $475.33 million, a 2.12% decrease between quarters.

1 … 573 574 575 576

Organisations

Palantir Technologies

274 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.